Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differential TdT expression in acute leukemia by flow cytometry: a quantitative study

N Farahat1, D Lens, R Morilla

  • 1Academic Department of Haematology and Cytogenetics, Royal Marsden Hospital, London, UK.

Leukemia
|April 1, 1995
PubMed
Summary

Quantitative flow cytometry of Terminal deoxynucleotidyl transferase (TdT) re-establishes its diagnostic value in acute leukemia. This method precisely differentiates acute lymphoblastic leukemia (ALL) from acute myeloid leukemia (AML), aiding in diagnosis and minimal residual disease detection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.

Nature genetics·1997
Same author

The human T-cell lymphotropic viruses types I/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia.

Leukemia·1997
Same author

The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long-term follow-up study.

British journal of haematology·1997
Same author

G-CSF mobilization of haemopoietic cell populations in SCID mice engrafted with human leukaemia.

Bone marrow transplantation·1997
Same author

Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia?

Leukemia·1997
Same author

Treatment of T-cell prolymphocytic leukemia with human CD52 antibody.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1997

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Terminal deoxynucleotidyl transferase (TdT) is a key enzyme in lymphocyte development.
  • Traditionally used as a diagnostic marker for acute lymphoblastic leukemia (ALL).
  • Recent findings of TdT in acute myeloid leukemia (AML) have raised questions about its diagnostic specificity.

Purpose of the Study:

  • To reevaluate the diagnostic significance of TdT in acute leukemia.
  • To compare the utility of flow cytometry with microscopy-based methods for TdT detection.
  • To establish quantitative TdT analysis for improved leukemia classification.

Main Methods:

  • Studied 58 acute leukemia cases using flow cytometry.
  • Quantified TdT expression with calibrated fluorescent beads.

Related Experiment Videos

  • Compared flow cytometry results with immunocytochemistry findings.

    • Main Results:

    • Highest TdT values observed in B-lineage ALL, lowest in AML.
    • Statistically significant differences (P < 0.0001) in TdT levels across leukemia types.
    • Flow cytometry provided more precise quantitative differences than immunocytochemistry.
    • TdT analysis aided in defining maturation stages in pre-B ALL and T-ALL.

    Conclusions:

    • Quantitative flow cytometry of TdT confirms its diagnostic value in acute leukemia.
    • This method offers improved differentiation between ALL and AML.
    • TdT flow cytometry has potential applications in monitoring minimal residual disease.